易方达标普生物科技人民币C(012866)
动态评分： 6.09分
投资组合
| 报告日期 | 代码 | 名称 | 类型 | 金额(万元) | 占期初比 |
| 2023-06-30 | BTAI | BioXcel Therapeutics Inc | 买入 | 149.49 | 0.46% |
| 2023-06-30 | BBIO | BridgeBio Pharma Inc | 买入 | 144.97 | 0.45% |
| 2023-06-30 | VRDN | Viridian Therapeutics Inc | 买入 | 144.49 | 0.45% |
| 2023-06-30 | TVTX | Travere Therapeutics Inc | 买入 | 142.92 | 0.44% |
| 2023-06-30 | PTGX | Protagonist Therapeutics Inc | 买入 | 140.3 | 0.43% |
| 2023-06-30 | MRNA | Moderna Inc | 买入 | 134.77 | 0.42% |
| 2023-06-30 | CPRX | Catalyst Pharmaceuticals Inc | 买入 | 127.35 | 0.39% |
| 2023-06-30 | BLUE | 蓝鸟生物 | 买入 | 116.3 | 0.36% |
| 2023-06-30 | INCY | 因塞特医疗 | 买入 | 115.62 | 0.36% |
| 2023-06-30 | ALT | Altimmune Inc | 卖出 | 99.88 | 0.31% |
| 2023-06-30 | GOSS | Gossamer Bio Inc | 卖出 | 98.74 | 0.3% |
| 2022-12-31 | VERV | Verve Therapeutics Inc | 买入 | 536.71 | 3.54% |
| 2022-12-31 | NVAX | 诺瓦瓦克斯医药 | 买入 | 532.52 | 3.52% |
| 2022-12-31 | TWST | Twist Bioscience Corp | 买入 | 483.03 | 3.19% |
| 2022-12-31 | BLUE | 蓝鸟生物 | 买入 | 452.58 | 2.99% |
| 2022-12-31 | NTLA | Intellia Therapeutics Inc | 买入 | 434.19 | 2.87% |
| 2022-12-31 | MRTX | Mirati Therapeutics Inc | 买入 | 432.84 | 2.86% |
| 2022-12-31 | IOVA | Iovance Biotherapeutics Inc | 买入 | 420.32 | 2.77% |
| 2022-12-31 | BHVN | Biohaven Ltd | 买入 | 410.33 | 2.71% |
| 2022-12-31 | CRSP | CRISPR Therapeutics AG | 买入 | 396.51 | 2.62% |
公告&资料
